scholarly journals Ambulatory vasodilator therapy in heart failure: systematic review of the literature and personal observational experience

1999 ◽  
Vol 1 (3) ◽  
pp. 263-268 ◽  
Author(s):  
Richard Pacher ◽  
Brigitte Stanek
2015 ◽  
Vol 21 (12) ◽  
pp. 989-999 ◽  
Author(s):  
Martha Abshire ◽  
Jiayun Xu ◽  
Diana Baptiste ◽  
Johana R. Almansa ◽  
Jingzhi Xu ◽  
...  

2006 ◽  
Vol 12 (5) ◽  
pp. 234-241 ◽  
Author(s):  
Andrés Martínez ◽  
Estrella Everss ◽  
José Luis Rojo-Álvarez ◽  
Domingo Pascual Figal ◽  
Arcadio García-Alberola

2018 ◽  
Vol 37 (4) ◽  
pp. S322
Author(s):  
H.R. Rosenblum ◽  
J. Wessler ◽  
A. Gupta ◽  
B. Bikdeli

Author(s):  
Chun Wai Wong ◽  
Jacopo Tafuro ◽  
Ziyad Azam ◽  
Duwarakan Satchithananda ◽  
Simon Duckett ◽  
...  

2021 ◽  
Vol 11 ◽  
Author(s):  
Julien Catherine ◽  
Christiane Jungels ◽  
Valerie Durieux ◽  
Coralie Deliens ◽  
Bogdan Grigoriu

New drugs come not only with benefits but also with unexpected toxicities which need to be promptly recognized and managed. Starting from a scholar case of acute heart failure with preserved ejection fraction following the administration of trabectedin (ET-743, Yondelis®) in a patient with a metastatic solitary fibrous tumor, we performed a systematic review of the literature encompassing the results of previous cardiac safety analysis published ten years ago, a review of clinical trials published during the last 10 years as well as single-case descriptions related to trabectedin cardiotoxicity. The estimated incidence of cardiac toxicity was 3,4% among patients receiving trabectedin, with recent data suggesting a higher rate of heart failure than previously recognized. Previous or concomitant anthracyclines exposure may represent a risk factor. Assaying for NT-pro-BNP may be useful for the early detection of individuals with trabectedin-induced heart failure.


2021 ◽  
Author(s):  
Jennifer Leung

Among individuals with heart failure (HF), concurrent depression and anxiety may impact the performance of self-management. Little is known about this relationship. The aim of this systematic review of the literature was to describe self-management, depression and anxiety in individuals with HF, and to explore the relationship among these variables. Studies included in the review were written in English, and measured HF self-management, and either or both depression and anxiety. Fourteen studies were included in the review. Overall, the findings on self-management performance were mixed. The levels of depression among individuals with HF were low overall, which was unexpected for this population, whereas findings on the levels of anxiety were mixed, with some authors reporting high levels of anxiety and some reporting low levels. Mixed findings were also noted in terms of the relationship between self-management, and both depression and anxiety.


2000 ◽  
Vol 9 (3) ◽  
pp. A166
Author(s):  
D. O'Connell ◽  
J.M. Lowe ◽  
P. Candlish ◽  
A. Wilkinson ◽  
J. Silberberg ◽  
...  

2021 ◽  
Author(s):  
Jennifer Leung

Among individuals with heart failure (HF), concurrent depression and anxiety may impact the performance of self-management. Little is known about this relationship. The aim of this systematic review of the literature was to describe self-management, depression and anxiety in individuals with HF, and to explore the relationship among these variables. Studies included in the review were written in English, and measured HF self-management, and either or both depression and anxiety. Fourteen studies were included in the review. Overall, the findings on self-management performance were mixed. The levels of depression among individuals with HF were low overall, which was unexpected for this population, whereas findings on the levels of anxiety were mixed, with some authors reporting high levels of anxiety and some reporting low levels. Mixed findings were also noted in terms of the relationship between self-management, and both depression and anxiety.


Sign in / Sign up

Export Citation Format

Share Document